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Abstract.  An understudied challenge within process mining is the area of pro-
cess change over time. This is a particular concern in healthcare, where patterns 
of care emerge and evolve in response to individual patient needs and through 
complex interactions between people, process, technology and changing organi-
sational structure. We propose a structured approach to analyse process change 
over time suitable for the complex domain of healthcare. Our approach applies a 
qualitative process comparison at three levels of abstraction: a holistic perspec-
tive summarizing patient pathways (process model level), a middle level perspec-
tive based on activity sequences for individuals (trace level), and a fine-grained 
detail focus on activities (activity level). Our aim is to identify points in time 
where a process changed (detection), to localise and characterise the change (lo-
calisation and characterisation), and to understand process evolution (unravel-
ling). We illustrate the approach using a case study of cancer pathways in Leeds 
Cancer Centre where we found evidence of agreement in process change identi-
fied at the process model and activity levels, but not at the trace level. In the 
experiment we show that this qualitative approach provides a useful understand-
ing of process change over time. Examining change at the three levels provides 
confirmatory evidence of process change where perspectives agree, while con-
tradictory evidence can lead to focused discussions with domain experts. The ap-
proach should be of interest to others dealing with processes that undergo com-
plex change over time. 
Keywords: process mining, cancer pathways, process change, concept drift, 
multi-level process comparison 
1 Introduction 
In general, process-mining research projects work with data collected over months or 
years and start with the assumption that the processes are largely unchanged during the 
period of study. In reality, there are many reasons why both the process and the data 
about that process might change over time. This is a particular concern in healthcare, 
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where patterns of care emerge and evolve in response to individual patient needs and 
through complex interactions between people, processes, technology and changing or-
ganisational structures.  Arguably many healthcare processes are in a constant state of 
flux and evolution. A better understanding of how to identify and model process change 
over time is important if process mining is to be applied effectively within healthcare. 
ThHFKDQJLQJQDWXUHRISURFHVVHVRYHUWLPHKDVEHHQWHUPHGµFRQFHSWGULIW¶E\WKH 
machine learning community [1]. It has been adopted in the process mining community 
and there is a growing literature exploring potential new approaches [2]±[4]. Three 
challenges when dealing with concept drift are: (1) change point detection, which aims 
to detect that a process change has taken place and the time where this occurred; (2) 
change localisation and characterisation, which aims to characterise the nature of a 
change and identify the changed elements of a process, and (3) change process evolu-
tion, which aims to unravel the more gradual evolution of a process over time periods. 
The standard approach to analysing process changes over time is to construct process 
models from different time periods in a large dataset and compare them to identify 
changes. A common application for comparing processes is for conformance checking, 
where a reference model is compared to the real behaviour recorded in the event log 
[5]. Partington et al. [6] proposed an approach for comparison by defining points for 
comparison with various metrics. However, Partington et al. was concerned with dif-
ferences in process between different clinical settings so their methods are not directly 
applicable to analysing concept drift. Furthermore, Partington et al.'s approach required 
the selection of specific clinical metrics that vary between different clinical domains. 
Bolt et al. [7] suggested another process-comparison approach by comparing frequen-
cies and percentages of the activities in the logs. This facilitated detailed comparison 
between each activity in two logs, but not between processes. Both of Partington et al. 
and Bolt et al. works are not directly related to process change analysis, but can be used 
for analysing concept drift or process change over time. 
In our exploratory study, we developed an approach to discovering and analysing 
changes over time in complex longitudinal healthcare data. Our case study examined 
process data related to the treatment of endometrial cancer over a 15 year period (2003-
2017) in one of the UK's largest cancer centres (Leeds Cancer Centre) with a specific 
focus on the routes to diagnosis. Process mining has been used and shown promising 
results to support process analytics in Oncology [8]. Our event logs were drawn from 
the Electronic Healthcare Record (EHR) system of Leeds Teaching Hospital NHS 
Trust. In earlier work with this data [9], [10], we had assumed the processes were 
largely unchanged during the time period but had not explicitly tested this.  We were 
aware that the time period was long, that the system, people and organisation had 
evolved and changed over time but we were not aware of specific process changes be-
fore we commenced the investigation. Our experience with applying process mining on 
MIMIC-III, an open-access database [11], [12] showed that a change in the system af-
fected the discovered process. The Leeds EHR system, Patient Pathway Manager Plus 
(PPM+) [13], [14], was developed in-house and we were fortunate in having access to 
the software developers of the system, the training team and clinical staff and senior 
clinicians involved in the process. Changes detected through our multi-level process 
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change analysis method could therefore be evaluated and explored with staff who help 
identify in potential causal links between changes detected in the data and in practice. 
2 Method 
2.1 General Method  
Our structured approach combined the well-established PM2 process mining method 
[15] with concept drift analysis [4]. Bose et al. [4] proposed to analyse process change 
by process change detection, localisation and characterisation, and unravelling process 
evolution. Our proposed approach applies process comparison at three different levels: 
process model, trace, and activity levels. We applied our approach to analyse the route 
to diagnosis of endometrial cancer. Fig 1 shows our general methodology. 
 
 
Fig. 1. General methodology for multi-level process change analysis  
Planning was done by defining business process, research questions, and team members 
in this study. The following definitions describe the main components of our study. 
Definition 1 (Event logs and traces). An event log E is a set of events (c, a, t). An 
event refers to an activity a which happened at a timestamp t and is related to a partic-
ular case c. A trace T is a sequence of events that happened to a case c ordered by 
timestamp t, where T E. In this study, a case represents a patient having a set of events 
that happened between the timestamps of referral and diagnosis of endometrial cancer. 
Definition 2 (Sub-logs). A sub-log S is a subset of an event log E based on a sub-
setting criteria. The subsetting should be done such that a trace is grouped in to a sub-
log with no duplication in other sub-logs. For this study, the subsetting was done based 
on the year of timestamp t where the activity label a is Diagnosis. The event log was 
split into sub-logs based on the year of diagnosis of each patient. There are clearly many 
subsetting options that could be adopted. 
Definition 3 (Process models). A process model M is a directed graph modelling 
the traces T in the event log E. Process model M draws activities a as nodes and the 
possible paths p between nodes as arcs from one node to another. Standard process 
mining algorithms can be used to discover process models with additional components, 
such as frequency of nodes and arcs as the occurrence of a and p in E, respectively.   
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2.2 Process Change Analytics 
Sub-logs were analysed at the process-model, trace, and activity levels to describe the 
behaviour of the processes of interest. A summary of the metrics used at each level is 
presented in Table 1.  
Table 1. Metrics for describing the behaviour of processes at multiple levels 
Level Metrics Description 
Model Replay fitness The proportion of traces in the log that can be reproduced in the 
process model.  
 Precision The proportion of the sequence of events allowed by the model 
which is not seen in the event log. 
 Generalisation The proportion of the model to reproduce future sequence of 
events of the process. 
Trace Duration The number of days of the pathway from Referral to Diagnosis. 
 Variant propor-
tion 
The proportion of variants in the sub-log that were one of the 
most frequent variants in the complete log. 
Activity Frequency The number of patients having a specific event within one year. 
 Percentage The percentage of patients having a specific event out of all pa-
tients within a year. 
 
Our general process model for the model-level comparison, was built using interactive 
Data-Aware Heuristics Miner (iDHM) in ProM 6.8 [16] from the complete event log 
from 2003 to 2017. The iDHM enables an exploration of the parameter space and sev-
eral heuristics, and focuses on the general pattern based on the most frequent activities. 
Our model level behaviour was described by the replay fitness, precision and generali-
sation [5] of each sub-log to the general model. Our trace-level behaviour was described 
by durations and variants of the traces in the sub-logs using bupaR [17]. Our activity-
level behaviour was described by activity frequency and its percentage in the sub-logs. 
We then adopted a visual-analytic approach to identifying possible changes by quanti-
tatively comparing visualisations of these aforementioned descriptions of process be-
haviour. 
 
2.3 Case Study: Route to diagnosis of Leeds patients diagnosed with 
endometrial cancer during 2003-2017 
We examined the route to diagnosis of Leeds patients diagnosed with endometrial can-
cer over an extended fifteen year time period. We used an anonymised event log from 
the PPM+ EHR that had been through significant data cleaning (documented in full in 
[9]) and extracted events related to the route to diagnosis for endometrial cancer. The 
route to diagnosis [18] or cancer waiting time [19] is seen as one of the important per-
formance indicators in cancer treatment. In the UK, it is monitored by Public Health 
England and forms a key benchmark for high quality cancer care.  
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Endometrial cancer is a type of cancer that affects the female reproductive system 
and is more common in women who have been through the menopause. The most com-
mon symptom is unusual vaginal bleeding, which is usually followed by a GP consul-
tation and referral to an Oncology specialist (Gynaecologist). The specialist conducts 
some tests, such as an ultrasound scan, a hysteroscopy or a biopsy. If diagnosed with 
endometrial cancer, further investigations might be needed to determine the cancer 
stage [20]. At the Leeds Cancer Centre, all these events have been coded in the PPM 
EHR since 2003 and should therefore be present in the extracted event log giving a rich 
data source for process mining of the pathway from GP referral to diagnosis. The PPM 
EHR includes nine tables relevant to our study and these tables contain broad categories 
of activity such as Referrals, Admission, and Surgery. 
3 Results 
3.1 Data extraction and processing 
We applied four selection criteria to create the study cohort. Patients were selected if 
they had i) a legitimate care relationship with Leeds Teaching Hospital NHS Trust 
(LTHT), ii) a primary diagnosis of endometrial cancer (ICD-10 code C54 or C55), iii) 
a diagnosis between 2003 and 2017, and iv) a diagnosis of endometrial cancer at max-
imum 120 days after referral to an oncology specialty. The last criteria was based on 
discussion with clinical experts, because a longer time period is implausibly long for 
the events to be related. Based on those criteria, 943 out of 1126 endometrial cancer 
patients (84%) were selected in this study. In total, there are 65,200 events selected or 
58 events per patient on average. 
From those selected patients, we extracted all time-stamped events recorded between 
GP Referral and Diagnosis, which resulted in 339 different activity types. For the pur-
pose of our study, we focus simply on the broad categories of activity represented by 
the nine tables. We split Admission and Discharge that were from the same table and 
split out Diagnostic Surgery from the Surgery table. The resulting 11 activities were 
agreed with clinical co-authors, they are: Referral, Outpatient, Consultation, Admis-
sion, Discharge, Investigation, Pathology, Diagnosis Surgery, Multi-Disciplinary 
Team Review (MDT Review), Diagnosis, and Surgery.  The event log contained 7,967 
events with the minimum 2, median 6, mean 6.3, and max 12 events per patient. 
 
3.2 Process model comparison 
Figure 2 shows the general process model based on process mining of the complete log 
for the full 15 years. For simplicity, the process model shows the eight most frequent 
activities and the most-frequent paths between them. The Outpatient, Consultation, and 
MDT Review activities appeared infrequently and were omitted from the process model 
to produce the simple diagram as shown in Fig. 2. The Outpatient activity appeared in 
149 out of 943 patients (16%), Consultation appeared in 152 out of 943 patients (16%), 
and MDT Review appeared in 231 out of 943 patients (24%). The general process model 
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was highly representative of the complete event log (replay fitness = 0.81, precision = 
0.83, generalisation = 0.99). 
 
 
Fig. 2. The directly-follows graph, originally produced by the iDHM plugin in ProM 6.8, shows 
process model of the pathway from referral to diagnosis. The pathway flows from left to right, 
with rectangles represent activities and arrows as flows from one activity to the other. Numbers 
on the arrows show the number of patients having the activity flows to the other activities. 
We split the complete event log into 15 sub-logs covering one calendar year each and 
tested each yearly sub-log for conformance against this general process model. The 
general process model remained reasonably representative of each yearly sub-log (me-
dian [inter-quartile range]: replay fitness = 0.86 [0.10], precision = 0.78 [0.03], and 
generalisation = 0.93 [0.06]). All measures were similar across years (see Fig. 3). Our 
qualitative assessment suggest possible changes in 2004 where the replay fitness and 
generalisation are increased and precision was dropped from the previous year, in 2011 
where the trace fitness was dropped while the generalisation increased, and in 2016 
where both trace fitness and precision were started to increase. We thus identified three 
periods of potentially significant change in 2003-2004, 2010-2011 and in 2015-2016. 
 
 
Fig. 3. Conformance to the general process model over years. The shaded areas show the periods 
where change might have occurred at the process model level. 
3.3 Trace comparison 
We examined the profile of trace duration from Referral to Diagnosis for each yearly 
sub-log to produce the box plots in Fig 4. There is no obvious qualitative pattern based 
on the distribution of the duration, except on the inter-quartile range (IQR). The IQR is 
generally decreasing across year, with exceptions on 2005 where the IQR increased 
from 42 to 71 days (68%), on 2008 where the IQR increased from 32 to 45 (39%), on 
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2010 where the IQR increased from 34 to 49 days (44%), on 2011 where the IQR in-
creased from 49 to 50 days (2%), and on 2015 where the IQR increased from 41 to 48 
days (18%). Based on those analysis, we identified five periods of potentially change. 
 
 
Fig. 4. Boxplot of number of days from GP Referral to Diagnosis by year of diagnosis. Dashed 
line shows target duration (31 days).  The shaded boxes show the periods where change might 
have occurred. 
Figure 5 shows the top ten trace variants (representing 52%) from the general model 
and the presence of those variants over the years. Those top ten trace variants show 
only seven activities, excluding Surgery. The first variant is the common pathway of 
patients who got the sequence of Referral (R), Investigation (I), Pathology (P), Diag-
nostic Surgery (DS), and finally got a Diagnosis (D) of endometrial cancer. The second 
variant is similar to the first one, but with no record of Investigation. The third variant 
is similar to the first, except that the patients were admitted after an Investigation. The 
three most common variants (median [IQR]) are R-I-P-DS-D (19[9]%), R-P-DS-D 
(10[7]%), and R-I-A-P-DS-D-Di (6[3]%). The qualitative distinction between years is 
the waving trend of the first variant and the decreasing trend of the other variants.  
 
 
Fig. 5. Summary of the trace variant comparison over years. Size represents the most frequent 
variants in percentage over the number of patients diagnosed in each year. 
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3.4 Activity comparison 
We plotted the total number of patients having each of the main activities over years. 
There is a sudden increase in almost all activities in 2003-2004. There was also a sudden 
increase in almost all activities in 2010-2011 except on Discharge, and a sudden de-
crease in all activities in 2015-2016. These three periods of change (see Fig.6) were 
also suggested in Section 3.2 when reviewing the model level. 
 
 
Fig. 6. The total number of patients having each of the main activities over years. The shaded 
areas show the periods where change might have occurred at the activity level. 
We plotted the percentage of each activity for the number of patients each year (see 
Fig. 7). We grouped the activities into frequent activities occurring in at least 60% pa-
tients, and infrequent activities occurring in less than 60% patients. The three most-
frequent activities in all years (median [inter-quartile range]) are Pathology (93[7]%), 
Diagnostic Surgery (87.5[9]%), and Investigation (80[16]%). The four most-infrequent 
activities in all years (median [inter-quartile range]) are MDT Review (12[20]%), Out-
patient (13[7]%), Surgery (15.5[23]%), and Consultation (16[24]%). Qualitatively, the 
period of 2010-2011 was marked by a change in the frequency of the four infrequent 
activities, while Discharge was decreased to be lower than the four infrequent activities. 
In 2013, the frequency of the infrequent activities were increased except for Outpatient. 
 
  
Fig. 7. Percentage of activity presence by the number of patients each year. The frequent activi-
ties are presented in solid black lines, the infrequent activities in solid grey lines, and the high-
varied activities in dashed grey lines. The shaded areas show the periods where change might 
have occurred at the activity level. The referral and diagnosis activities are not presented, but 
both had 100% activity presence in all year groups.  
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4 Discussion 
For our case study of endometrial cancer care in Leeds Cancer Centre, we followed the 
PM2 methodology, with the exception of Process Improvement and Support. It is in 
these blind cases where the presence or characterisations of changes are not known in 
advance that an exploratory approach is appropriate. Our approach supports this explo-
ration through a qualitative, multi-level perspective for detecting, localising and char-
acterising change in processes. Graphical data visualisations supported discussions 
DERXWSURFHVVHYROXWLRQDQGFKDQJHZLWKGRPDLQH[SHUWVDQGPDNHVXVHRIKXPDQV¶
natural pattern-seeking capacities. We found that such discussions provoked deep re-
flection on the changing nature of the process over time and generated hypotheses about 
potential causal links between changes detected in the data and changes in practice.  
These hypotheses can then be tested by further, more tightly focused process and 
data analysis. In that respect, our approach is perhaps just a starting point for further 
exploratory studies. For example, in this case study, we split a fifteen year event log 
into 15 yearly sub-log but further division of the log into months, weeks, days or hours 
can be used to isolate potential change events of interest for further study.  
Our approach is based on Bose et al.'s process change analysis: detection, localisa-
tion and characterisation, and unravelling [4]. We have improved on Bose et al.'s ap-
proach by considering the detection of changes from multiple levels, rather than just at 
the activity level. Bose et al. suggest that the best place to start analysing process change 
is by detecting that a process changes has taken place. If that is the case, the next steps 
are to identify the time periods at which changes happened and characterise the nature 
of change. The alternative approach described by Partington et al. requires the domain 
expert to pre-characterise the expected differences that they want to detect and localise. 
In contrast, our approach did not require prior specification of the changes and instead 
uses domain experts in the later stage of what Bose et al describe as ³Unravelling´. This 
supports initial exploration without over-burdening collaborators or when the collabo-
rators are not able to pre-specify the expected differences. 
 
4.1 Change detection 
Changes were detected at all three levels: five at the trace level and three at model and 
activity levels. From our blinded exploration of our case-study process, we cannot attest 
to the validity of these detections nor can we know about any true process changes that 
were not detected. Future work using simulations could attempt to determine the sensi-
tivity of our suggested approach to changes in the magnitude and characteristics of pro-
cess changes. 
 
4.2 Change localisation and characterisation 
Assuming that the detected changes were true changes, we have localised those changes 
to the 2010-2011 and 2015-2016 periods. These localisations were supported by agree-
ment between changes in metric values across multiple levels. The usefulness of our 
multi-level approach is that the changes detected at one level can guide focused inves-
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tigation of the same period at other levels. For our case study, no change was inde-
pendently detected at the trace level in 2003-2004 despite detection at the model and 
activity level. The duration analysis also shows possible changes in 2005 and 2008, 
where the IQR of durations were increased. A review of the trace durations led us to 
consider that the median duration in 2016 ZDV WKH ILUVWH[DPSOHRID \HDU¶VPHGLDQ
duration lying outside the interquartile range of the previous year. Nevertheless, agree-
ment in the localisation of changes lends support to the validity of the detected changes. 
The aforementioned, post-hoc review of trace durations is an example of how our 
approach facilitates characterising change at levels where there were not found when 
investigated in isolation. The different median duration of traces was the only trace-
level characterisation of change in 2016. The strongest evidence for a 2016 change 
came from the sharp decline in trace frequencies at the activity level, and was supported 
by an unexpected rise in replay fitness at the model level. This multi-dimensional per-
spective of a suspected change event informs a more-rounded, complex picture of 
changes that can be taken to domain experts for discussion. 
 
4.3 Unravelling process evolution 
The rich characterisation forms the substance for discussion with clinical experts as we 
collaborate to explain the mechanism and consequences of the detected changes. Our 
discussion with clinical experts to unravel process evolution found several findings 
based on three different levels of process comparison. The process model discovered 
(see Fig. 2) has been agreed to reflect the general pathways of referral to the diagnosis 
of endometrial cancer. There was no significant change of the duration and sequence 
from referral to the diagnosis that the clinical experts were aware of, which confirmed 
the perspective in the trace-level comparison (see Fig. 4 and Fig. 5). A concern was 
raised by clinical experts about some trace variants (see Fig. 5) that have an Admission 
(A) without a Discharge (Di) (variant 7 and 10). Further analysis on these traces re-
vealed that the discharge event happened after diagnosis, hence not captured in the trace 
variants. In the activity level comparison, clinical experts highlighted their concern on 
the finding that MDT Review is one of the infrequent activities, while in fact, all patients 
would need to be discussed in the MDT review at some point of their cancer treatment. 
Further discussion revealed that the MDT reviews usually happened after diagnosis.  
Another important discussion about the activity-level comparison is that the system 
from which the data was collected is evolving. For example, it is shown in Figure 6 that 
the Outpatient activity started to appear for patients diagnosed in 2006 and the Consul-
tation activity started to appear in patients diagnosed in 2008. Further discussion with 
the PPM development team confirmed that the system was modified in these years to 
start recording these activities. There were also improvements to the PPM system that 
introduced automatic imports from other systems (pathology, for example) that were 
previously captured manually with the effect that data volumes and the reliability of the 
data increased when the system was improved. There are opportunities for further anal-
ysis to examine the effect of these changes in the system on the process over time. 
 
11 
4.4 Reflection on our proposed approach 
We discovered our general process model using interactive Data-Aware Heuristics 
Miner (iDHM) plug-in [16] but other options, like Inductive Miner and Fuzzy Miner or 
being entirely informed by clinical guidance, might have produced different process 
models. We used iDHM because its heuristic approach allowed us to get a process 
model at the desired level of detail. The visualisations provided in the plug-in made it 
possible to explore the directly-follows graph, dependency graph, causal net, or Petri 
net. Future work will look at the sensitivity of conclusions to the choice of plug-in. 
Further flexibility evident in our approach is the rule for splitting the logs into sub-
logs. We split sub-logs based on the calendar year of diagnosis but an equally reasona-
ble method would be to split the log to enforce a uniform number of traces in each sub-
log. The consequence of the first method is that the number of traces in each sub-log 
varies and the consequence of the second is that the duration of the sub-log varies. We 
addressed the consequence of our choice by analysing the frequency in percentage in-
stead of the number of occurrences. 
5 Conclusion 
This paper presented an approach to analyse process changes over time and provided a 
real-life case study. The case study examined the route from GP Referral to Diagnosis 
of endometrial cancer in Leeds Cancer Centre patients. The general method followed 
in this study is the PM2, with a focus on process analytics stage to analyse process 
changes over time. Process change detection, localisation, and characterisation were 
carried out at three different levels of comparison: model, trace and activity. This ap-
proach allows to detect changes when comparing one year with another. One important 
limitation of the proposed approach is that it is not able to detect the exact point in time 
when the change actually occurred. Moreover, this approach could not detect changes 
back and forth during the same year however, repeating the method with a finer grained 
time interval would allow the change point to be more accurately detected. 
Future work could review the splitting method, the comparison metrics, and the ref-
erence model discovery. The comparison metrics used in this study are defined to rep-
resent three different level of details but further work might examine other metrics for 
comparisons. The reference model discovery can be improved by considering clinical 
guideline as the reference model, or by including only valid traces in the discovery step. 
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